[Paclitaxel and simultaneous radiotherapy in stage-III non-small-cell bronchial carcinoma]

Strahlenther Onkol. 1996 May:172 Suppl 1:5-8.
[Article in German]
No abstract available

Publication types

  • Clinical Trial

MeSH terms

  • Adult
  • Aged
  • Antineoplastic Agents, Phytogenic / administration & dosage
  • Antineoplastic Agents, Phytogenic / adverse effects
  • Antineoplastic Agents, Phytogenic / therapeutic use*
  • Carcinoma, Bronchogenic / drug therapy*
  • Carcinoma, Bronchogenic / pathology
  • Carcinoma, Bronchogenic / radiotherapy*
  • Carcinoma, Non-Small-Cell Lung / drug therapy*
  • Carcinoma, Non-Small-Cell Lung / pathology
  • Carcinoma, Non-Small-Cell Lung / radiotherapy*
  • Chemotherapy, Adjuvant
  • Female
  • Humans
  • Lung Neoplasms / drug therapy*
  • Lung Neoplasms / pathology
  • Male
  • Middle Aged
  • Neoplasm Staging
  • Paclitaxel / administration & dosage
  • Paclitaxel / adverse effects
  • Paclitaxel / therapeutic use*
  • Pilot Projects
  • Radiation-Sensitizing Agents / administration & dosage
  • Radiation-Sensitizing Agents / adverse effects
  • Radiation-Sensitizing Agents / therapeutic use*
  • Radiotherapy Dosage
  • Radiotherapy, Adjuvant
  • Treatment Outcome

Substances

  • Antineoplastic Agents, Phytogenic
  • Radiation-Sensitizing Agents
  • Paclitaxel